⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
ALGS News
Aligos Therapeutics, Inc. Common Stock
Aligos Therapeutics to Present at the Cantor Global Healthcare Conference
globenewswire.com
ALGS
Aligos Therapeutics Announces First Participant Dosed in the Phase 1 Study of its Potentially Best-in-Class Antisense Oligonucleotide ALG-170675 by its Partner Amoytop in China
globenewswire.com
ALGS
Form 8-K
sec.gov
ALGS
Aligos Therapeutics Reports Recent Business Progress and Second Quarter 2026 Financial Results
globenewswire.com
ALGS
Aligos Therapeutics Reports Recent Business Progress and Second Quarter 2026 Financial Results
globenewswire.com
ALGS
Aligos Therapeutics to Announce 2nd Quarter 2026 Financial Results on August 6, 2026
globenewswire.com
ALGS
Complicated Urinary Tract Infections Market Report, Analyzes Treatment Needs Across Elderly, Diabetic, and Immunosuppressed Populations
globenewswire.com
ABBV
PFE
GALT
VKTX
LPCN
ALGS
LLY
Aligos Therapeutics Announces the Completion of Enrollment in the Phase 2 B-SUPREME Study of Pevifoscorvir Sodium Under Development for the Treatment of Chronic HBV Infection
globenewswire.com
ALGS
Aligos Therapeutics Receives Upfront Payment of $25M USD from the Exclusive License Deal of Pevifoscorvir Sodium in Greater China for Chronic Hepatitis B Virus Infection
globenewswire.com
ALGS
Algenesis Wins ACS Green Chemistry Challenge Award for Soleic®, the First Fully Biodegradable, High-Performance Polyurethane Platform Validated for a Microplastic-free World
prnewswire.com
ALGS